STOCK TITAN

Thermo Fisher Scientific Inc. - TMO STOCK NEWS

Welcome to our dedicated news page for Thermo Fisher Scientific (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Thermo Fisher Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Thermo Fisher Scientific's position in the market.

Rhea-AI Summary
Thermo Fisher Scientific and the National Minority Quality Forum collaborate to increase diversity in clinical trials and improve health equity
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific CEO to present at Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
Rhea-AI Summary
Thermo Fisher Scientific CEO to present at Handelsbanken Life Science Innovation Day
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
Rhea-AI Summary
Audax Private Equity has completed the sale of CorEvitas, a leading provider of real-world evidence for medical treatments, to Thermo Fisher Scientific. CorEvitas leverages proprietary data to help pharmaceutical customers uncover clinical insights. Under Audax's ownership, CorEvitas completed five add-on acquisitions and launched six new clinical registries. Audax has raised $5.25 billion for its seventh flagship fund and $774 million for its debut lower middle market strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. has priced an offering of $2.95 billion aggregate principal amount of senior notes. The offering includes $600 million of 4.953% senior notes due 2026, $750 million of 4.977% senior notes due 2030, $1 billion of 5.086% senior notes due 2033, and $600 million of 5.404% senior notes due 2043. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) reported Q2 2023 revenue of $10.69 billion, a 3% decline YoY, with core organic revenue growth at 2%. GAAP diluted EPS was $3.51, while adjusted EPS was $5.15. The company announced a definitive agreement to acquire CorEvitas for approximately $0.9 billion and revised 2023 revenue guidance to $43.4 billion to $44.0 billion, with adjusted EPS of $22.28 to $22.72.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
dividends
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. has announced the election of Jenny Johnson, President and CEO of Franklin Resources, Inc., to its board of directors. Johnson's extensive experience and leadership in the finance industry make her a valuable addition to the board.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
management
Rhea-AI Summary
Audax Private Equity has entered into an agreement to sell CorEvitas, a provider of real-world evidence for medical treatments, to Thermo Fisher Scientific. The transaction is expected to be completed by the end of 2023. CorEvitas has integrated five add-on acquisitions during its hold period, which have strengthened its value proposition. Under Audax' ownership, CorEvitas has also experienced organic growth and expanded into international markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
none
Thermo Fisher Scientific Inc.

NYSE:TMO

TMO Rankings

TMO Stock Data

215.76B
380.42M
0.18%
92.21%
0.68%
Other Measuring and Controlling Device Manufacturing
Manufacturing
Link
US
Waltham

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.